Ireland· IE-PA-PA2059/069/003
Flucloxacillin 2000 mg powder for solution for injection/infusion
A flucloxacillin product containing flucloxacillin sodium, registered in Ireland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Flucloxacillin is registered in 12 of 19 countries.
Countries holding a registration under ATC J01CF05 (flucloxacillin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Flucloxacillin · ATC J01CF05
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- FLUCLOXACILLIN SODIUM
- Manufacturer
- Fresenius Kabi Deutschland GmbH
- Country
- Ireland (IE)
- ATC code
- J01CF05
- ATC class
- Flucloxacillin
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2059/069/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flucloxacillin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumFloxapen 2 gEugia Pharma (Malta)
- CzechiaFLUCLOXACILLIN FRESENIUS KABIFresenius Kabi s.r.o., Praha
- SwitzerlandFloxapen 2 g i.v., Pulver zur Herstellung einer Injektions-/InfusionslösungTeva Pharma AG
- IcelandFlucloxacillin WHWilliams & Halls ehf.*
- NetherlandsFlucloxacilline Eugia 2 g, poeder voor oplossing voor injectie of infusieEugia Pharma (Malta) Limited
- United KingdomFloxapen 125mg/5ml syrupActavis UK Ltd
- GermanyFlucloxStragen Pharma Gmbh
- SwedenFlucloxacillin EQL Pharma 1 g Filmdragerad tablettEQL Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Floxapen, Flucloxacillin Kabi
- Belgium · Floxapen, Flucloxacilline Fresenius Kabi
- Czechia · Flucloxacillin Fresenius Kabi, Koryxa
- Germany · Fluclox, Flucloxacillin Altamedics
- Denmark · Flucloxacillin Orion, Nerbutix
- Estonia · Finogi
- Finland · Flucloxacillin Orion
- France · Flucloxacilline Arrow
- United Kingdom (Northern Ireland) · Floxapen, Flucloxacillin
- Greece · Flucloxacillin Cooper, Skovolen
- Croatia · Finogi, Flukloksacilin Altamedics
- Hungary · Flucloxacillin Panpharma
- Iceland · Flucloxacillin Wh
- Italy · Flucacid, Flucloxacillina K24 Pharmaceuticals
- Luxembourg · Floxapen, Floxapen 1 G Inj
- Malta · Finogi, Flucloxacillin
- Netherlands · Flucloxacillin Focus Care Pharmaceuticals, Flucloxacillin Sodium Aurobindo
- Norway · Nerbutix
- Portugal · Finogi, Floxapen
- Sweden · Flucloxacillin Eql Pharma, Flucloxacillin Orion
- Slovenia · Flukloksacilin Altamedics, Flukloksacilin Kabi
- Slovakia · Flucloxacillin Fresenius Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61a172ec-20ba-48fc-8e86-3f5860a83e84 GET /v1/drugs/61a172ec-20ba-48fc-8e86-3f5860a83e84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection/infusion",
"routes": [
"Intraarticular use",
"Intramuscular use",
"Intrapleural use",
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"J01CF05"
],
"strength": null,
"pa_number": "PA2059/069/003",
"substances": [
"FLUCLOXACILLIN SODIUM"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "13/11/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about flucloxacillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.